| 000 | 01781 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515082524.0 | ||
| 264 | 0 | _c20071211 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a0961-8368 | ||
| 024 | 7 |
_a10.1110/ps.072924907 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWyler, Emanuel | |
| 245 | 0 | 0 |
_aInhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO. _h[electronic resource] |
| 260 |
_bProtein science : a publication of the Protein Society _cSep 2007 |
||
| 300 |
_a2013-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnkyrin Repeat |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aDNA, Complementary |
| 650 | 0 | 4 |
_aEscherichia coli _xgenetics |
| 650 | 0 | 4 | _aGenes, Reporter |
| 650 | 0 | 4 |
_aGreen Fluorescent Proteins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aI-kappa B Kinase _xchemistry |
| 650 | 0 | 4 |
_aKidney _xcytology |
| 650 | 0 | 4 |
_aLuciferases _xanalysis |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPlasmids |
| 650 | 0 | 4 | _aProtein Structure, Tertiary |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 650 | 0 | 4 |
_aUbiquitin _xmetabolism |
| 650 | 0 | 4 |
_abeta-Galactosidase _xanalysis |
| 700 | 1 | _aKaminska, Monika | |
| 700 | 1 | _aCoïc, Yves-Marie | |
| 700 | 1 | _aBaleux, Françoise | |
| 700 | 1 | _aVéron, Michel | |
| 700 | 1 | _aAgou, Fabrice | |
| 773 | 0 |
_tProtein science : a publication of the Protein Society _gvol. 16 _gno. 9 _gp. 2013-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1110/ps.072924907 _zAvailable from publisher's website |
| 999 |
_c17295614 _d17295614 |
||